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Identification of Compounds that Bind
Mitochondrial F1F0 ATPase by Screening
a Triazine Library for Correction of Albinism
be identified by the production of novel phenotypes in
a cellular or embryonic system. An affinity matrix made
of the immobilized active compound is used to identify
biological targets.
Traditionally, active molecules selected and modified
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Summary The triazine scaffold was chosen due to its ease of ma-
nipulation and structural similarity to purine and pyrimi-
A triazine-based combinatorial library of small mole- dine, since purine and pyrimidine binding sites are com-
cules was screened in albino murine melanocytes to mon in proteins [7]. Purine- and pyrimidine-based
identify compounds that induce pigmentation. Six com- libraries have already been demonstrated to be active
pounds (of 1536 screened) produced at least 3-fold in various biological systems [18–22].
increases in pigmentation. Immunohistochemical stud- Thus, this study utilizes a novel tagged library ap-
ies demonstrated that the compounds conferred cor- proach to accelerate the conversion of a hit compound
rect routing of the mistrafficked enzyme tyrosinase, to an efficient affinity matrix. Six active small molecules
which is critical to normal melanogenesis. Affinity obtained from library screening in albino melanocytes
matrices of the immobilized compounds allowed the demonstrate that inhibition of the F1F0 mitochondrial
cellular target to be identified as the mitochondrial ATPase is a potential therapeutic target for the correc-
F1F0-ATP synthase. Oligomycin and aurovertin B, tion of OCA2.
small molecules known to inhibit the mitochondrial
ATP synthase, were shown to compete with the tri-
Resultsazine-based compounds for their cellular target in al-
bino melanocytes and confer similar effects on pig-
Identification of Triazine-Based Compoundsmentation and tyrosinase rerouting. This is the first
that Induce Pigmentation in Melan-p1 Cellsdemonstration of the mitochondrial ATP synthase as
Twenty-one compounds were identified as candidatea potential therapeutic target for restoring pigmenta-
tion in albino melanocytes. active drugs after an initial survey of a 1536 compound
library. Candidates were rescreened in triplicate, re-
Introduction sulting in six confirmed active compounds (Figure 1A).
Three inactive but structurally related compounds were
Oculocutaneous albinism type 2 (OCA2), the most com- chosen as controls (Figure 1B). The ability of the active
mon form of albinism, results from mutations in the pink- compounds to stimulate pigmentation in melan-p1 cells
eyed dilution gene (p ) [1]. Unlike oculocutaneous albi- is shown in Figure 2. Plotting the induction of pigmenta-
nism type 1, which results from mutations in tyrosinase, tion as either “melanin/mg protein total mg protein per
the rate-limiting enzyme in melanogenesis, patients with well” or “melanin/mg protein” produced similar results
OCA2 express active tyrosinase [2]. Previous studies in (compare Figures 2Ai and 2Aii). This illustrates that the
p null melanocytes (melan-p1 cells), derived from the enhanced pigmentation is due to an absolute increase
murine equivalent of OCA2, demonstrate incorrect traf- in the amount of melanin in the cell population, rather
ficking of tyrosinase and increased retention in the endo- than selective toxicity of the compounds on cells ex-
plasmic reticulum [3–5]. This misrouting can be corrected pressing reduced levels of melanin. Differences were
by transfection with an expression vector encoding wild- observed in the nature of the induction of pigmentation
type p, or by incubating melan-p1 cells with the vacuolar by the six compounds. MPc11, MPd11, APc25, and
ATPase inhibitor bafilomycin A1, the ionophore monen- APc32 were more potent at inducing pigmentation (Fig-
sin, or ammonium chloride [6]. ures 2A and 2B) and showed greater levels of pigment
Chemical genetics is a relatively new field of research induction when melan-p1 cell received repeat doses of
that has the potential to provide powerful tools for identi- the drug (Figures 2D and 2E). The compounds PPa01
fying novel drug candidates and their cellular target(s) and PPj01 failed to display a redosing effect (Figures
[7–13]. Small molecules replace the mutation-inducing 2C and 2F).
agents or X-ray irradiation employed by classical genet-
ics. Combinatorial techniques [14–17] allow for the rapid
Identification of the Mitochondrial F1F0-ATPscreening of large numbers of small molecules that can
Synthase as a Cellular Target
Eluted proteins from affinity matrix-conjugated com-*Correspondence: seth.orlow@med.nyu.edu
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Figure 1. Chemical Structure of the Triazine Compounds that Induce Pigmentation in Melan-p1 Cells
(A) Structure and designation of screened compounds that pigment albino melan-p1 melanocytes.
(B) Structure and designation of the inactive compounds used as controls in this study.
pigmenting drugs (Figures 3A and 3B). In addition, a 30 antibodies against the  and  subunits of the ATPase
kDa protein was bound specifically to the affinity matrix- (Figures 3E and 3F). The  subunit sometimes migrated
conjugated compounds MPc11, MPd11, APc25, and as a doublet. Oligomycin was a more potent competitor
APc32. However, this band was less prominent among of drug target binding than aurovertin. In keeping with
the eluted protein from matrices conjugated with the the ATPase as a target for pigmentation induction, both
compounds PPa01 and PPj01 (data not shown). Preincu- oligomycin and aurovertin induced pigmentation in
bating the cell lysate with free compound diminished melan-p1 cells (Figure 3G); however, oligomycin was
the presence of the 55 kDa doublet in the eluate (Figure the more potent stimulator of pigmentation.
3C). The free compound acts as a competitor of target
binding to the matrix-conjugated compound. Ion-Trap
Active Compounds Induce Pigmentation in Melan-p1mass spectrometry identified the 55 kDa doublet as the
Cells by Correcting Tyrosinase Trafficking via Targeting and  subunits of the mitochondrial F1F0-ATP syn-
of the Mitochondrial ATPasethase (Figure 3D). Two inhibitors of the mitochondrial
Previous immunohistochemical analyses of the melano-ATPase, oligomycin and aurovertin, were also found to
somal proteins tyrosinase and tyrosine-related protein-1compete with the binding of theandATPase subunits
(TRP-1) in melan-p1 cells demonstrated that both pro-to the matrix-conjugated compounds (Figure 3C).
teins reside in different cellular compartments from thatTo further demonstrate that the cellular target is the
observed in normal melanocytes [3–6]. TRP-1 and tyrosi-mitochondrial ATPase, proteins bound to the matrix-
conjugated compounds were blotted and probed with nase immunostaining of normal melanocytes reveals a
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punctuate, cytoplasmic distribution of both tyrosinase gericin are known to disrupt Na/H exchange and K/
H exchange in the Golgi, respectively [25]. NH4Cl isand TRP-1, and this distribution pattern is consistent
also capable of melanin induction in melan-p1 cells,with their location in melanosomes. However, in melan-
presumably by directly increasing the pH of various en-p1 cells, tyrosinase in restricted to the perinuclear region
domembrane systems [3, 26]. We propose that ourwhile TRP-1 shows increased misrouting to the cell pe-
screened compounds induce melanin synthesis inriphery (Figure 4A) [3–6]. Treating melan-p1 cells with
melan-p1 cells by inhibiting mtATPase-mediated trans-the pigmenting compounds caused an alteration in the
port of H ions, resulting in the alkalination of the cyto-trafficking of tyrosinase and TRP-1 and produced in-
sol. This hypothesis is supported by the pigmentingcreased colocalization of the two proteins that resem-
effects of two known inhibitors of the mtATPase, oligo-bled the distribution seen in normal melanocytes (Fig-
mycin and aurovertin B. We are confident that inhibitionures 4C and 4D). Western blot analysis of lysates
of the mtATPase, rather than general mitochondrial tox-obtained from melan-p1 cells at 72 hr after drug treat-
icity, induces melan-p1 cell pigmentation because previ-ment showed that there was no significant increase in
ous results from our laboratory have shown that neitherthe amount of tyrosinase and TRP-1 protein (data not
FCCP (a mitochondrial uncoupler) nor arsenical com-shown). Thus, the triazine compounds appear to induce
pounds (which target the mitochondria) induce pigmen-pigmentation in melan-p1 cells by correcting tyrosinase
tation in these melanocytes (data not shown).and TRP-1 trafficking. This effect could be seen at rela-
It is interesting to compare the induction of pigmenta-tively early time points after the addition of drug and
tion induced by an inhibitor of the V-ATPase, bafilo-before the onset of detectable increases in melanin syn-
mycin, and that produced by inhibitors of the mtATPase.thesis. Treatment of melan-p1 cells with oligomycin pro-
Bafilomycin is more effective at inducing pigmentationduced a similar correction of tyrosinase and TRP-1 traf-
and, typically, could produce levels of melanin accumu-ficking (Figure 4E).
lation in melan-p1 cells that are 10-fold above the basalThe MitoFluor594 mitochondrial membrane potential-
level. The triazine-based compounds and oligomycinsensing dye demonstrated that the novel pigmentation-
can, on average, produce increases in melan-p1 cellinducing triazine compounds influenced mitochondrial
pigmentation that are 3- to 4-fold above the basal level.membrane potential in a similar manner to the mitochon-
Both aurovertin B and oligomycin were shown to bedrial F1F0-ATP synthase inhibitor, oligomycin. This ef-
capable of inducing pigmentation in melan-p1 cells. Oli-fect was seen as soon as 3 hr after drug treatment
gomycin could induce pigmentation at significantly
(Figure 5). By contrast, bafilomycin, a vacuolar ATPase
lower doses than aurovertin (Figure 3G). This difference
inhibitor, had a minimal influence on mitochondrial mem-
was also reflected in the ability of oligomycin and auro-
brane potential, as detected by the MitoFluor594 dye. vertin to compete with mtATPase binding to affinity ma-
trices of the triazine-based compounds. A greater
amount of aurovertin was required to reduce the bindingDiscussion
of the triazine-based compounds to the  subunit of
the mtATPase (Figure 3F). In addition, it was difficult toIn this study, by screening a tagged triazine-based,
achieve aurovertin competition for the binding of the
small-molecule library we demonstrated that the mito-
triazine-based compounds to the  subunit of the mtAT-
chondrial F1F0-ATP synthase (mtATPase) is a potential
Pase (Figure 3E).
target protein for rescuing melanocytes from the albi- Differences in the ability of the six triazine-based com-
nism phenotype. This is achieved by restoring tyrosi- pounds to induce pigmentation in melan-p1 cells can
nase transport to melanosomes, the normal site of mela- be seen after redosing studies. Typically, melan-p1 cells
nin synthesis and deposition. In addition, we report that were incubated with one dose of drug for 72 hr prior
oligomycin and aurovertin B, compounds that also tar- to melanin assay. We have found that the compounds
get and inhibit the mitochondrial ATPase, both induce MPc11, MPd11, APc25, and APc32 can produce a signif-
melanin synthesis in melan-p1 cells. icantly greater induction of pigmentation when cells are
Melan-p1 cells have defective early processing of the given three doses of drug, spaced 24 hr apart, over a
key melanogenic enzyme, tyrosinase [3, 4]. Previous 72 hr period. Using this dosing regime, even suboptimal
research has shown that a variety of compounds are doses of drug can then induce levels of pigmentation
capable of restoring melanin synthesis in melan-p1 cells in melan-p1 cells that rival that induced by bafilomycin.
[3, 6]. These compounds include tyrosine, ammonium This suggests that these compounds are unstable in the
chloride, bafilomycin A1, concanamycin, monensin, and tissue culture environment and degrade over a 24 hr
nigericin. Results from our laboratory suggest that bafi- period. It is interesting to note that two compounds that
lomycin A1 and monensin induce melanin synthesis in induce pigmentation in melan-p1, PPa01 and PPj01, did
melan-p1 cells by facilitating tyrosinase processing from not show a redosing effect and are, presumably, stable
the ER to the Golgi. This is achieved by increasing the in tissue culture for at least 72 hr.
pH in either the ER or the ER-Golgi intermediate com- A number of studies of melan-p1 pigmentation were
partment [6]. Bafilomycin A1 and concanamycin A are completed to investigate whether the triazine-based
vacuolar-type (H)-ATPase (V-ATPase) inhibitors [23]. compounds could act synergistically with themselves
V-ATPases transport H ions into various endomem- or other known inducers of pigmentation. However, no
brane systems and cellular organelles, such as endo- synergistic effects were recorded, although some addi-
somes and lysosomes. Monensin and nigericin are iono- tive effects could be seen when combining oligomycin
phores that induce melanin synthesis in melan-p1 cells dosing with the triazine-based compounds MPc11,
MPd11, and APc25 (data not shown).at micromolar concentrations [6, 24]. Monensin and ni-
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Figure 2. Quantitative Assessment of the Induction of Pigmentation in Melan-p1 Cells by Screened Triazine-Based Compounds
(A) (i) Dose-response study for compounds MPc11 and MPd11. Dose-response data for MPa11, an inactive compound of similar structure,
are included for comparison. Cytotoxicity reaches 25% at doses of 3 M MPc11 or MPd11, but not MPa11. (ii) Adjusting the dose-response
data for total milligrams of protein per well does not diminish the degree of pigmentation induction.
(B) Dose-response study for compounds APc25 and APc32. Dose-response data for APc26, an inactive compound of similar structure, is
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Further studies of these novel melan-p1 pigmenting pounds rescue albino melanocytes by perturbing
intracellular pH, similar to another pigmenting com-compounds include the detailed characterization of their
binding to the mtATPase. The mtATPase consists of two pound, bafilomycin, which inhibits the vacuolar ATP
synthase. This study demonstrates the power ofparts, F1 and F0. F1 is the catalytic portion and consists
of five subunits. F0 consists of 10 subunits in mitochon- chemical genetics for discovering potential new drugs
and drug targets for the treatment of diseases.dria and is arranged as a membrane-embedded, proton-
conducting channel [27]. It is known that aurovertin B
Experimental Proceduresbinds to subunit  of the mtATPase [28]. The exact
subunit targeted by oligomycin is not known, although
Development of the Small-Molecule Library
one subunit (the oligomycin sensitivity-conferring pro- The design and production of the tagged triazine library have been
tein) is essential for conferring sensitivity to inhibition reported previously [29]. Briefly, a solid-phase method was used to
construct a tagged triazine library, where three building blocks wereby oligomycin [27]. Further detailed biochemical studies
prepared separately and assembled orthogonally to yield 1536will be needed to decipher which mtATPase subunit(s)
highly pure compounds. Each library compound contained one ofis the precise molecular target for our triazine-based
a variety of triethyleneglycol (TG) linkers at one of the diversity sitespigmenting compounds. In addition, elongated melano-
of the triazine scaffold.
somes and melanin deposition in endosome-like struc-
tures were observed in melan-p1 cells treated with 50 Cell Culture
Melan-a (a/a, P/P) is an immortalized melanocyte line derived fromnM bafilomycin A1. Whether similar structures are seen
C57BL/6J mice wild-type at the p locus. Melan-p1 is an immortalizedin melan-p1 cells after treatment with our mtATPase
melanocyte line from C57BL/6J mice lacking p gene transcripts duebinding pigmenting compounds is not yet known.
to overlapping deletions [30]. Melan-p1 cells were maintained inWe have successfully demonstrated the power of a
RPMI culture medium containing 2 mM L-glutamine, 100,000 IU/L
tagged library approach for efficient forward chemical penicillin, 100 mg/L streptomycin, 5% fetal bovine serum and 200
genetics, in this case demonstrating a novel role for the nM tetradecanoyl phorbol acetate at 37C and 5% CO2.
mtATPase in restoring pigmentation in albino melano-
Small-Molecule Screening in Melan-p1 Cellscytes. Our small-molecule library facilitates the connec-
Lyophilized library compounds were resuspended in DMSO to ation of a hit compound to the affinity matrix by incorpo-
final concentration of 10 mM. Each compound was added to onerating a linker directly to the compounds before their
well of a 24-well tissue culture plate containing 1  105 melan-p1
phenotypic screening. The same tagged library ap- cells at a final concentration of 5 M. Cells were incubated with
proach can be readily applied to other cellular screens. each compound for 72 hr. Changes in pigmentation were detected
by melanin assay (see below). Cytotoxicity was assessed initially
by visual inspection of the cells and defined by the presence ofSignificance
dead, floating, or misshapen cells with reduced dendricity. A protein
assay was then completed if cytotoxicity was apparent. Toxic com-
We have adopted a chemical genetics approach to pounds were rescreened at 1 M.
identify a novel potential drug target for the most com-
Melanin Assaymon form of albinism, oculocutaneous albinism type
Cells were rinsed with phosphate-buffered saline (PBS) and lysed2. A triazine-based combinatorial library of 1536 small
with an extraction buffer (50 mM Tris [pH 7.5], 2 mM ethylenediaminemolecules was screened in albino melanocytes. Six
tetraacetic acid [EDTA] [pH 7.8], 150 mM NaCl, 1% Triton X-100)
compounds were identified that could induce signifi- with protease inhibitor cocktail at 4C. Cell extracts were then spun
cant levels of pigmentation. The cellular target of each at 12,000 rpm for 10 min at 4C. The remaining pellet was assayed
for melanin by rinsing twice with ethanol-ether (1:1) and dissolvingcompound was identified as the mitochondrial F1F0-
in 200 l 2 N NaOH in 20% DMSO at 60C. A 100 l aliquot of theATP synthase. Two known inhibitors of the ATP syn-
resulting solution was then measured for absorbance at 490 nm.thase were shown to also induce pigmentation in al-
bino melanocytes and to compete with the triazine
Isolation and Identification of Drug Cellular Target(s)
compounds for binding to the ATP synthase. Oculocu- Protein was extracted from cells by incubation with extraction buffer
taneous albinism type 2 is characterized by perturbed (1 mM CaCl2, 150 mM NaCl, 10 mM Tris [pH 7.4], 1% Triton X-100,
1 mM PMSF, plus one tablet of protease inhibitor cocktail [Roche]intracellular trafficking of two melanocyte-specific
per 20 ml buffer) for 5 min on ice. Crude lysate was centrifuged atproteins, tyrosinase and tyrosinase-related protein-1.
13,000 rpm for 10 min. The protein concentration of the supernatantThe triazine-based compounds were shown to correct
was measured by the Bradford assay (Bio-Rad) and adjusted to athis defect and their ability to inhibit the mitochondrial
final concentration of 1 g/l prior to affinity chromatography.
F1F0-ATP synthase was demonstrated by a mitochon- 25–50 l agarose affinity matrix-conjugated compound was
drial inner membrane potential-sensitive dye. We pro- washed with 1 ml bead buffer (10 mM Tris [pH 7.4], 5 mM NaF, 250
mM NaCl, 5 mM EDTA, 5 mM EGTA, 0.1% Triton X-100 plus proteasepose that these novel triazine-based pigmenting com-
included for comparison. Cytotoxicity reaches 25% at doses of 4 M APc25 or APc32, but not APc26.
(C) Dose-response study for compounds PPa1 and PPj1. Dose-response data for PPj14, an inactive compound of similar structure, is included
for comparison. The induction of pigmentation begins to level off at doses of  6 M PPa1 or PPj1.
(D) Repeated dosing of the compound APc32 produces greater increases in pigmentation than a single dose alone. Repeat doses were spaced
24 hr apart over a 72 hr time course. Two different doses were used: three doses of 1 M triazine compound (labeled on the x axis as “3 
1 M”) or three doses of 1.5 M triazine compound (labeled on the x axis as “3  1.5 M”).
(E) A similar repeat dosing effect could be seen for the compound MPd11 and was also observed for the compounds MPc11 and APc25 (data
not shown).
(F) This repeat dosing effect was not a feature of the compound PPj1 and was also absent from the compound PPa1 (data not shown).
Chemistry & Biology
1256
Figure 3. Studies to Identify the Target as the Mitochondrial F1F0-ATP Synthase; Demonstration of Competition for the Drug Target by Known
Inhibitors of the Mitochondrial F1F0-ATP Synthase; Demonstration that Known Inhibitors of the Mitochondrial F1F0-ATP Synthase Can Induce
Pigmentation in Melan-p1 Cells
(A) Drug target study for the compound MPc11 in melan-p1 cells. Eluted proteins were separated by 7.5% SDS-PAGE. Lanes: Eth., ethanolamine-
conjugated affinity matrix; a11, MPa11 (inactive compound)-conjugated affinity matrix; c11, MPc11-conjugated affinity matrix.
(B) The prominent 55 kDa band that is specific for pigmenting compounds can be resolved into a doublet by 6%–12% gradient SDS-PAGE.
Correction of Albinism by Inhibition of mtATPase
1257
inhibitor cocktail [Roche]). Matrices were incubated with 50–200 g and 5% CO2. The slides were analyzed with a digital fluorescence
microscope (LSM510; Carl Zeiss). All data were analyzed with a 20of protein extract, plus an identical volume of bead buffer at 4C or
30C. For studies of competition of drug binding to cellular target, lens and processed with Adobe Photoshop 7.0 (Adobe Systems).
the competitor was added to the mixture of protein extract/bead
buffer and incubated at 4C for 30 min prior to incubation with the Acknowledgments
matrix. The supernatant containing unbound proteins was removed
by centrifugation, and the matrices were washed seven times with This work was supported in part by Public Health Service grant
1 ml bead buffer. Proteins bound to the matrices were eluted by AR41880 (S.J.O.).
incubation with 50 l Laemmli buffer (Bio-Rad) at 94C for 3 min.
Eluted proteins were separated by 7.5% or 10% SDS-PAGE and
Received: May 1, 2004visualized by silver staining (Amersham). Prominent protein bands
Revised: May 27, 2004specific to active matrices were excised from each gel and identified
Accepted: June 9, 2004by Ion Trap mass spectrometry (NYU Protein Analysis Facility, Skir-
Published: September 17, 2004ball Institute of Biomolecular Medicine).
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the greater pigmenting effect of bafilomycin alongside the pigmentation induced by aurovertin and oligomycin.
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Figure 4. Immunomicroscopic Analysis of
the Effect of Triazine-Based Pigmentation In-
ducers on the Distribution of Tyrosinase and
Tyrosinase-Related Protein-1 in Melan-p1
Cells
Immunohistochemical analysis of tyrosinase
(detected by the pep-7 antibody) and TRP-1
(detected by the mel-5 antibody) trafficking
in melan-p1 cells. All images are taken 12 hr
after the addition of the drug to cells. The
yellow color indicates areas of overlapping
signal from tyrosinase (Tyr) and TRP-1. Com-
pounds were used at doses that typically in-
crease pigmentation in melan-p1 cells (mag-
nification 600).
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